Royal Bank Of Canada Summit Therapeutics Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 3,799 shares of SMMT stock, worth $75,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,799

Previous 109,934 96.54%

Holding current value

$75,144

Previous $2.41 Million 97.22%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$17.52 - $23.46 $1.86 Million - $2.49 Million	-106,135 Reduced 96.54%	3,799 $67,000
Q3 2024 Nov 14, 2024	BUY	$6.89 - $31.93 $642,072 - $2.98 Million	93,189 Added 556.52%	109,934 $2.41 Million
Q2 2024 Aug 14, 2024	BUY	$2.39 - $10.92 $12,638 - $57,744	5,288 Added 46.16%	16,745 $130,000
Q1 2024 Nov 05, 2024	SELL	$2.55 - $5.07 $13,484 - $26,810	-5,288 Reduced 31.58%	11,457 $47,000
Q1 2024 May 15, 2024	SELL	$2.55 - $5.07 $55,686 - $110,718	-21,838 Reduced 65.59%	11,457 $47,000
Q4 2023 Feb 14, 2024	BUY	$1.67 - $2.83 $23,072 - $39,099	13,816 Added 70.93%	33,295 $86,000
Q3 2023 Nov 14, 2023	BUY	$1.54 - $2.42 $11,289 - $17,741	7,331 Added 60.35%	19,479 $36,000
Q2 2023 Aug 14, 2023	BUY	$1.32 - $2.81 $15,211 - $32,382	11,524 Added 1846.79%	12,148 $30,000
Q1 2023 May 15, 2023	SELL	$1.38 - $5.41 $2,717 - $10,652	-1,969 Reduced 75.94%	624 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.68 - $5.31 $1,763 - $13,768	2,593 New	2,593 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.38 $1,490 - $3,855	-1,620 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.0 - $3.45 $8,452 - $14,579	-4,226 Reduced 72.29%	1,620 $4,000
Q4 2021 Feb 14, 2022	BUY	$2.45 - $5.64 $6,213 - $14,303	2,536 Added 76.62%	5,846 $15,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $8,553 - $14,646	1,771 Added 115.07%	3,310 $17,000
Q2 2021 Aug 16, 2021	BUY	$5.15 - $8.46 $7,925 - $13,019	1,539 New	1,539 $11,000

Others Institutions Holding SMMT

# of Institutions

232

Shares Held

83.1M

Call Options Held

1.66M

Put Options Held

2.56M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.98B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Summit Therapeutics Inc. Transaction History